RAFAEL
PÉREZ GARCÍA
Forscher bis um 2018
Universidad de Alcalá
Alcalá de Henares, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Alcalá (9)
2023
-
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration
Clinical Kidney Journal, Vol. 16, Núm. 11, pp. 2254-2261
2021
-
A high magnesium concentration in citrate dialysate prevents oxidative stress and damage in human monocytes in vitro
Clinical Kidney Journal, Vol. 14, Núm. 5, pp. 1403-1411
2020
2019
-
Statins and antiplatelet agents are associated with changes in the circulatory markers of endothelial dysfunction in chronic kidney disease
Nefrologia, Vol. 39, Núm. 3, pp. 287-293
2018
-
Asymmetric cellulose triacetate is a safe and effective alternative for online haemodiafiltration
Nefrologia, Vol. 38, Núm. 3, pp. 315-320
2017
-
Citrate dialysate does not induce oxidative stress or inflammation in vitro as compared to acetate dialysate
Nefrologia, Vol. 37, Núm. 6, pp. 630-637
-
Residual Renal Function in Hemodialysis and Inflammation
Therapeutic Apheresis and Dialysis, Vol. 21, Núm. 6, pp. 592-598
2016
-
Guideline for dialysate quality of Spanish Society of Nephrology (second edition, 2015)
Nefrologia, Vol. 36, Núm. 3, pp. e1-e52
-
Guía de gestión de calidad del líquido de diálisis (LD) (segunda edición, 2015)
Nefrologia, Vol. 36, Núm. 3, pp. e1-e52